IMMATICS N.V's ticker is IMTX and the CUSIP is N44445109. A total of 52 filers reported holding IMMATICS N.V in Q3 2021. The put-call ratio across all filers is 0.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $18,000 | +5.9% | 2,175 | -0.5% | 0.00% | – |
| Q1 2022 | $17,000 | -54.1% | 2,185 | -21.1% | 0.00% | -100.0% |
| Q4 2021 | $37,000 | -35.1% | 2,769 | -36.9% | 0.00% | 0.0% |
| Q3 2021 | $57,000 | -50.4% | 4,390 | -55.7% | 0.00% | -50.0% |
| Q2 2021 | $115,000 | -25.8% | 9,920 | -28.7% | 0.00% | -33.3% |
| Q1 2021 | $155,000 | -67.4% | 13,908 | -68.4% | 0.00% | -72.7% |
| Q4 2020 | $475,000 | +654.0% | 44,047 | +688.8% | 0.01% | +450.0% |
| Q3 2020 | $63,000 | – | 5,584 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 697,431 | $8,048 | 3.11% |
| Nantahala Capital Management | 2,284,895 | $26,367,688 | 2.55% |
| Sofinnova Investments, Inc. | 3,041,487 | $35,098,760 | 2.30% |
| Paradigm Biocapital Advisors LP | 1,984,813 | $22,904,742 | 1.77% |
| Affinity Asset Advisors, LLC | 300,000 | $3,462,000 | 1.21% |
| Perceptive Advisors | 3,491,500 | $40,291,910 | 1.17% |
| 683 Capital Management, LLC | 1,350,000 | $15,579,000 | 1.12% |
| SPHERA FUNDS MANAGEMENT LTD. | 617,173 | $7,122,176 | 1.11% |
| Samsara BioCapital, LLC | 396,000 | $4,569,840 | 0.80% |
| Logos Global Management LP | 500,000 | $5,770,000 | 0.78% |